News & events

Print

Alzheimer Society of Canada participates in CETA roundtable examining benefits of enhanced R&D to patients

OTTAWA, Nov. 7, 2013 - The Alzheimer Society of Canada will join several patient advocacy groups today at a roundtable hosted by The Hon. Ed Fast, Minister of International Trade, and The Honourable Rona Ambrose, Minister of Health, to discuss the impact of the Comprehensive Economic and Trade Agreement on Canadian research and development.

Mimi Lowi-Young, Chief Executive Officer of the Alzheimer Society of Canada, will participate in the discussion and will be available to provide members of the media her perspective on this important issue afterward.

Details of the event are as follows:

      What: Patient Roundtable on CETA
      When: Thursday, November 7, 2013, 11:45 a.m.
      Where: Mental Health Commission of Canada, 100 Sparks Street, Suite 600, Ottawa

As an organization dedicated to providing help to nearly 750,000 Canadians living with Alzheimer's disease and other dementias, the Alzheimer Society of Canada is supportive of all efforts that stand to benefit patients through innovative research and development.

The Alzheimer Society of Canada continues to advocate for a Canadian Alzheimer's Disease and Dementia Partnership, with a mandate to assemble dementia experts, government officials, health-care providers, researchers and people who are personally impacted by the disease to facilitate and implement a national dementia strategy.

Members of the media interested in speaking with Mimi Lowi-Young are asked to attend the event or contact Rosanne Meandro (contact information below).

About the Alzheimer Society of Canada
The Alzheimer Society is the leading nationwide health charity for people living with Alzheimer's disease and other dementias. Active in communities across Canada, the Society offers help for today through our programs and services, and hope for tomorrow by funding research into the cause, prevention and a cure.

Media contact:

Rosanne Meandro
Director, Media Relations
Direct: 416-847-8920
Mobile: 416-669-5715
rmeandro@alzheimer.ca


Last Updated: 11/07/16
Back to top